Find trials
Search tips

Lesional Skin In Hidradenitis Suppurativa (HS)

Overview

About this study

The purpose of this research is to identify an association between bacterial species and strains and active hidradenitis suppurativa (HS) lesions using metagenomic shotgun sequencing and culture and whole genome sequencing of HS lesions.

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Male or female, at least 18 years old

Exclusion Criteria: 

  • Current use of any systemic antibiotics within 60 days
  • Current use of topical antibiotics for the last two weeks
  • Patients who have the comorbidities listed below:
    • Active infection
    • Patients with incomplete medical record

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 07/15/2024. Questions regarding updates should be directed to the study team contact.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Afsaneh Alavi, M.D.

Contact us for the latest status

Contact information:

Jessica Hafeman

5074226964

hafeman.jessica@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20598531

Mayo Clinic Footer